SKLB-163

CAS No. 1255099-06-9

SKLB-163( SKLB 163 | SKLB163 )

Catalog No. M27829 CAS No. 1255099-06-9

SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 Get Quote
10MG 447 Get Quote
25MG 714 Get Quote
50MG 1017 Get Quote
100MG 1368 Get Quote
500MG 2673 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SKLB-163
  • Note
    Research use only, not for human use.
  • Brief Description
    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
  • Description
    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SKLB 163 | SKLB163
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    GABAA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1255099-06-9
  • Formula Weight
    405.92
  • Molecular Formula
    C18H16ClN3O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClCC(=O)Nc1ccc2nc(SCC(=O)NCc3ccccc3)sc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Divya K Nair, et al. Synthesis of imidazopyridines from the Morita-Baylis-Hillman acetates of nitroalkenes and convenient access to Alpidem and Zolpidem. Org Lett. 2012 Sep 7;14(17):4580-3.
molnova catalog
related products
  • PD 169316

    A potent, selective p38 MAPK inhibitor with IC50 of 89 nM.

  • CC-99677

    CC-99677 (Gamcemetinib) is a selectively targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune diseases that translates biochemical potency into cellular potency as demonstrated by potent inhibition of heat shock protein 27 (HSP1) phosphorylation in LPS-activated monocyte THP-27 cells via a nucleophilic aromatic substitution (SNAr) mechanism.

  • Bisabolangelone

    Bisabolangelone has anti-tumor, anti-inflammatory, anti-microbial, and antioxidant activities, it inhibits dendritic cell functions by blocking MAPK and NF-κB signaling.Bisabolangelone (BISA), isolated from the roots of Angelica koreana, has many pharmacological activities, such as anti-tumor, anti-microbial, antioxidant, and anti-inflammatory activities.?